1. LECTURES/PANELS
MassBio Policy Leadership Breakfast January 7, 2011
Panel: Healthcare Reform: SuccessfulImplementation without Stifling Innovation
BIO Europe March 9, 2010
Panel: Cost-effectiveness and Reimbursement: Why Development Stage Companies Should Care
Commission on Professionals in Science and Technology November 5, 2009
Panel: Biotechnology . . . Innovation,Opportunity and Public Policy
BIO Europe November 2, 2009
Panel: US Healthcare Reform: The International Impact on Innovation and the Business of Biotech
Cleveland Clinic: 2009 Medical Innovation Summit October 7, 2009
Panel: Five Ways Health Care Reform Will change Your Life as an Innovator
Developing a BioScience Economy in conjunction with NCSL Annual Meeting July 22, 2009
“What is Biotechnology and Why Investment is Essential”
House of Representatives Briefing on Biosimilars April 20, 2009
“Creating a pathway that protects patients and incentivizes future treatments and cures ”
US Chamber of Commerce January 15, 2009
Panel: The Future of Comparative Effectiveness
Federal Trade Commission November 21, 2008
Panel: Follow-On Biologic Drugs: Framework for Competition and Continued Innovation
American Bar Association November 6, 2008
Panel: Biologics Balancing Competition and Innovation
Mid-Atlantic BIO October 24, 2008
Panel: Follow-on Biologics: How Would FDA Approval Change the Competitive Landscape?
US-Danish Biomedical Innovation and Health meeting September 10, 2008
“Some Economic Thoughts on Healthcare”
University of Virginia: Intensive Scholars Institute: Developing Leadership for Health Care Systems June 11, 2008
Follow-On Biologics
Wharton School of Business April 9, 2008
“Policy Matters”
BIOTECanada: Meeting on Subsequent Entry Biologics January 24, 2008
“The Market of Subsequent Entry Biologics”
JPMorgan Therapeutics Day: Regulatory and Legislative Trends & Outlook December 18, 2007
“Outlook for Patent Reform and Follow-On Biologics”
CBI’s Forumon Evidence Based Medicine December 5, 2007
Panel: Current Public Sector EBM Initiatives and Outlook on the Future
George Washington University - Seminar series on FDA November 19, 2007
“Some Thoughts on Follow-On Biologics”

2. Biosimilars Today September 25, 2007
“The Economics of Follow-On Biologics”
Canaccord Adams Global Growth Conference August 9, 2007
Panel: Follow-On Biologics
University of Virginia: Intensive Scholars Institute: Developing Leadership for Health Care Systems June 26, 2007
Follow-On Biologics
